Dr. Hatfield, expert in HIV prevention, shares his real-world experience implementing long-acting injectable PrEP into clinical practice, including challenges he’s overcome and insights for the Canadian perspective as long-acting options are approved in Canada.

After this program, participants will be able to:

• Highlight the importance of choice to tailor PrEP options to the individual experience
• Review key clinical trial data and real-world evidence supporting the use of long-acting injectable PrEP approved in Canada
• Discuss the implementation of long-acting injectable PrEP options in clinical practice
• Apply real-world US experience with long-acting injectable PrEP to regional Canadian practice